This retrospective investigation of Medicare claims data compared the risk of anaphylaxis among intravenous iron products.
This randomized trial compares the effects of daily iron supplementation vs placebo on maternal Plasmodium infection risk and neonatal outcomes among pregnant women living in a malaria endemic area.
This randomized trial found that among blood donors with normal hemoglobin levels, low-dose iron supplementation reduced time to recovery of hemoglobin concentration.
This randomized trial reports that antenatal multiple micronutrient compared with iron–folic acid supplementation did not reduce infant mortality to age 6 months but resulted in a non–statistically significant reduction in stillbirths and significant reductions in preterm births and low birth weight.
Zlotkin and coauthors reported the findings from a double-blind, cluster randomized trial of the effect of iron fortification on malaria incidence in infants and young children in Ghana. In an accompanying Editorial, Prentice and coauthors discuss iron fortification and malaria risk in children.